WALL STREET JOURNAL - Latest News - N.Y. Museum Issues Economic-Impact Report

WALL STREET JOURNAL - Latest News - N.Y. Museum Issues Economic-Impact Report 

A study of the economic impact of the Museum of Modern Art, in New York, claims that in less than three years from the institutions reopening in 2004, the museum will have generated $2-billion in revenue for the city, reports The Wall Street Journal.

SAT: Seek A Tutor? 
For a test that you can't technically "fail," there's an awful lot of groaning going on today over the Class of 2006 in regard to its SAT scores. On Wednesday, a seven-point slip in the average score among students taking the test translated into the lead story in Section D of The Wall Street Journal.

Claim not time to find insurance lacking 
Its the downside of the housing boom: Many homeowners are now significantly underinsured. Americans have been pouring money into their homes in recent years, adding everything from marble bathrooms to fancy backyard decks.

(AFX UK Focus) 2006-09-01 06:41 GMT: Sanofi-Aventis cardiovascular drug Multaq application rejected by US FDA 
LONDON (AFX) - Sanofi-Aventis said the Food and Drug Administration rejected the French drug maker's application to sell Multaq, a cardiovascular drug the company had hoped would become a blockbuster, the Wall Street Journal reported.

Judge overturns Vioxx award vs Merck: WSJ 
NEW YORK (Reuters) - A federal judge overturned a $50 million award handed down by jury against Merck & Co. MRK.N earlier this month in a case of a former FBI agent who had blamed the withdrawn painkiller Vioxx for his heart attack, the Wall Street Journal reported on its web site on Wednesday.